Evidence map›Paper›PMID 37053125›Full record

ArticleMMWR. Morbidity and mortality weekly report2023

Update on Wild Poliovirus Type 1 Outbreak - Southeastern Africa, 2021-2022.

Elizabeth Davlantes, Sharon A Greene, Farrell A Tobolowsky, Oladayo Biya, Eric Wiesen, Fikru Abebe, Mesfin B Weldetsadik, Victor A Eboh, Mike N Chisema, Balbina da Conceição Mário and 24 more

Open access · diamondAbstract read
In one paragraph

Article in MMWR. Morbidity and mortality weekly report, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Elizabeth Davlantes
Sharon A Greene
Farrell A Tobolowsky
Oladayo Biya
Eric Wiesen
Fikru Abebe
Mesfin B Weldetsadik
Victor A Eboh
Mike N Chisema
Balbina da Conceição Mário
Florian Tinuga
Patricia Mupeta Bobo
Colline Koline Chigodo
Ghanashyam Sethy
Jan-Marcus Hellström
Abdou Moumouni Goundara
Marie-Eve Burny
Jonas C Mwale
Jaume Jorba
Koketso S Makua
Wayne Howard
Lerato Seakamela
Samuel Okiror
Andrea Thompson
Asma Ali
Dhoud Samba
Chukwuemeka Agbo
Lusamba Kabamba
Anthony Kazoka
Delayo Laurel Zomahoun
Fadinding Manneh
Khalid Abdelrahim
Chris Kamugisha
Abubakar Sadiq Umar

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the Global Polio Eradication Initiative (GPEI) began in 1988, the number of wild poliovirus (WPV) cases has declined by >99.99%. Five of the six World Health Organization (WHO) regions have been certified free of indigenous WPV, and WPV serotypes 2 and 3 have been declared eradicated globally (1). WPV type 1 (WPV1) remains endemic only in Afghanistan and Pakistan (2,3). Before the outbreak described in this report, WPV1 had not been detected in southeastern Africa since the 1990s, and on August 25, 2020, the WHO African Region was certified free of indigenous WPV (4). On February 16, 2022, WPV1 infection was confirmed in one child living in Malawi, with onset of paralysis on November 19, 2021. Genomic sequence analysis of the isolated poliovirus indicated that it originated in Pakistan (5). Cases were subsequently identified in Mozambique. This report summarizes progress in the outbreak response since the initial report (5). During November 2021-December 2022, nine children and adolescents with paralytic polio caused by WPV1 were identified in southeastern Africa: one in Malawi and eight in Mozambique. Malawi, Mozambique, and three neighboring countries at high risk for WPV1 importation (Tanzania, Zambia, and Zimbabwe) responded by increasing surveillance and organizing up to six rounds of national and subnational polio supplementary immunization activities (SIAs).* Although no cases of paralytic WPV1 infection have been reported in Malawi since November 2021 or in Mozambique since August 2022, undetected transmission might be ongoing because of poliovirus surveillance gaps and testing delays. Efforts to further enhance poliovirus surveillance sensitivity, improve SIA quality, and strengthen routine immunization are needed to ensure that WPV1 transmission has been interrupted within 12 months of the first case, thereby preserving the WHO African Region's WPV-free status.

Indexed as

PoliomyelitisPoliovirusAdolescentChildDisease EradicationDisease OutbreaksHumansImmunization ProgramsMalawiPoliovirus Vaccine, OralPopulation SurveillancePoliovirus Vaccine, Oral

Identifiers

PMID37053125
PMCPMC10121257
OpenAlexW4365443780

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.